(Q35166734)

6 August 2017

1 reference

title

The current position of allogeneic and autologous BMT in multiple myeloma (English)

1 reference

6 August 2017

The Current Position of Allogeneic and Autologous BMT in Multiple Myeloma (English)

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

23 November 2023

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

23 November 2023

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

23 November 2023

author name string

D. Samson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1283547

23 November 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1283547

23 November 2023

publication date

1 January 1992

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428199209061562

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

23 November 2023

1 reference

6 August 2017

volume

7 Suppl

1 reference

6 August 2017

page(s)

33-38

1 reference

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199209061562

Detection of minimal residual myeloma after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209061562

Increase in clonogenic tumour cells in bone marrow of patients with multiple myeloma treated with vincristine, doxorubicin, and methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209061562

Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209061562

Multiple myeloma treated with high dose intravenous melphalan

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

23 November 2023

3

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

23 November 2023

4

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

Intensive treatment of multiple myeloma and criteria for complete remission

23 November 2023

10

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

Circulating monoclonal B lymphocytes in multiple myeloma

23 November 2023

12

1 reference

https://api.crossref.org/works/10.3109/10428199209061562

23 November 2023

Identifiers

1 reference

6 August 2017

1 reference